Regencell Bioscience (NASDAQ:RGC) Stock Price Down 4.2% – What’s Next?

Regencell Bioscience Holdings Limited (NASDAQ:RGC)’s share price fell 4.2% during mid-day trading on Monday . The stock traded as low as $11.78 and last traded at $11.96. 95,263 shares were traded during mid-day trading, a decline of 99% from the average session volume of 7,994,849 shares. The stock had previously closed at $12.48.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Regencell Bioscience in a report on Monday, November 17th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Regencell Bioscience Price Performance

The company’s 50-day moving average price is $15.43.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in RGC. Geode Capital Management LLC boosted its stake in shares of Regencell Bioscience by 5,637.5% in the 2nd quarter. Geode Capital Management LLC now owns 391,066 shares of the company’s stock valued at $6,664,000 after purchasing an additional 384,250 shares during the last quarter. Squarepoint Ops LLC acquired a new position in Regencell Bioscience in the second quarter valued at $1,701,000. BNP Paribas Financial Markets bought a new stake in Regencell Bioscience during the second quarter valued at $768,000. XTX Topco Ltd bought a new stake in Regencell Bioscience during the third quarter valued at $598,000. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Regencell Bioscience during the 2nd quarter worth about $222,000. Institutional investors own 0.13% of the company’s stock.

About Regencell Bioscience

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.